Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Clinical trial NCT03761225 · COMPLETED
Trial details
- NCT number
- NCT03761225
- Sponsor
- AB Science
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2020-12-15
- Enrollment
- 714
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.